Abacavir and Lamivudine
- Product NDC
- 65862-900
- 11-digit product format
- 658620900
- Labeler code
- 65862
- Product ID
- 65862-900_72b6fd39-d4be-45f9-ad9c-11af12dc99b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir and Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA206151
- Marketing category
- ANDA
- Marketing start
- 2017-03-28
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-900-30 | 65862090030 | 1 BOTTLE in 1 CARTON (65862-900-30) > 30 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2017-03-28 | 0000-00-00 | No | No | Current |